GKOS GLAUKOS
Health Care · Russell 2000
Next earnings: not announced yet
What 17 analyst firms say about GLAUKOS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
17 rated views · 19 analyst/firm records · 17 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 18 reports on GKOS from 14 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 9 raised their price target and 1 left it unchanged.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: BTIG Research raised its target from $205.00 (set 12 Oct 2026) to $234.00 on 29 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Ryan Zimmerman | Buy | 29 Oct 2026 | 234.00 USD |
| Citigroup | Joanne Wuensch | Buy | 29 Oct 2026 | Conflicting reports · excluded |
| Goldman Sachs | David H Roman | Buy | 30 Apr 2026 | 168.00 USD |
| H.C. Wainwright | Yi Chen | Buy | 29 Oct 2026 | 248.00 USD |
| Jefferies | Michael Sarcone | Buy | 22 Sep 2026 | Conflicting reports · excluded |
| JPMorgan | Allen Gong | Buy | 29 Oct 2026 | 240.00 USD |
| Mizuho | Anthony Petrone | ConflictConflicting reports · excluded | 29 Oct 2026 | 225.00 USD |
| Needham | David Saxon | Buy | 29 Oct 2026 | 251.00 USD |
| Piper Sandler | Adam Maeder | Buy | 29 Oct 2026 | 240.00 USD |
| Stephens | George Sellers | Buy | 2 Jan 2026 | 145.00 USD |
| Stephens | Mason Carrico | Buy | 30 Jul 2026 | 215.00 USD |
| Stifel | Tom Stephan | Buy | 29 Oct 2026 | 225.00 USD |
| Truist | Richard Newitter | Buy | 29 Oct 2026 | 255.00 USD |
| UBS | Danielle Antalffy | Hold | 28 Jul 2026 | 150.00 USD |
| UBS | Patrick Wood | Hold | 28 Jul 2026 | 172.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Larry Biegelsen | Buy | 29 Oct 2026 | 226.00 USD |
| William Blair | Steven Lichtman | Buy | 9 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 28 Oct 2026 | 174.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:05 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.